What's Happening?
During a live recording of The PQI Podcast at NCODA’s 2026 International Fall Summit, hematologist-oncologist and author Chadi Nabhan, MD, MBA, FACP, addressed the growing trend of patients bringing AI-generated treatment recommendations to their medical
appointments. Dr. Nabhan discussed how patients are utilizing AI to interpret scan reports and visit summaries. He also shared his personal experience of using AI to understand complex medical procedures, specifically CAR T-cell therapy, in simpler terms. The conversation highlighted the potential for AI to assist healthcare teams in matching patients with suitable clinical trials, indicating a shift in how technology might integrate into patient care and medical decision-making processes.
Why It's Important?
The integration of AI into patient-facing healthcare, particularly in oncology, signifies a significant evolution in how medical information is accessed and understood by the public. This development is important because it empowers patients with more information, but also introduces challenges for healthcare providers who must navigate AI-generated recommendations that may not always align with established medical protocols or individual patient needs. The ability of AI to simplify complex medical jargon could improve patient comprehension and engagement in their own care. However, it also necessitates a new skill set for oncologists to effectively communicate with patients about AI outputs, ensuring that medical decisions remain evidence-based and tailored to each patient's unique circumstances. This trend could influence future healthcare policies regarding AI use and patient education.
What's Next?
As AI technology continues to advance, healthcare providers will likely face an increasing number of patients presenting AI-generated medical advice. This will necessitate the development of clear guidelines and best practices for discussing and evaluating such recommendations within the clinical setting. Medical education programs may need to incorporate training on how to effectively communicate with patients about AI, address potential misinformation, and leverage AI tools responsibly. Furthermore, the role of AI in identifying suitable clinical trials could expand, potentially accelerating research and treatment development in oncology. The ongoing dialogue between patients, AI, and medical professionals will shape the future landscape of cancer care, emphasizing the need for a balanced approach that harnesses technology while prioritizing patient safety and expert medical judgment.
Beyond the Headlines
The emergence of AI in patient-doctor interactions raises profound ethical and legal questions. While AI can democratize access to information, it also introduces concerns about data privacy, algorithmic bias, and the ultimate responsibility for medical outcomes when AI plays a role in recommendations. The 'black box' nature of some AI models could make it difficult to understand how certain conclusions are reached, challenging the principles of informed consent and transparency in healthcare. Moreover, the reliance on AI could inadvertently widen the digital divide, as not all patients have equal access to these technologies. Addressing these deeper implications will be crucial for ensuring that AI serves as a beneficial tool in healthcare, enhancing rather than undermining the human element of patient care and trust in medical professionals.













